OVARIAN CANCER and US: Researchers Identify Genetic Mutation That May Alter Patients' Response To Cancer Therapeutics

Monday, July 09, 2007

Researchers Identify Genetic Mutation That May Alter Patients' Response To Cancer Therapeutics

Researchers Identify Genetic Mutation That May Alter Patients' Response To Cancer Therapeutics: "Researchers from Eli Lilly & Company and the Phoenix-based Translational Genomics Research Institute (TGen) today announced finding a novel recurring mutation of the gene AKT1 in breast, colorectal and ovarian cancers. "

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.